Michel Pansiéri

Platelet Glycoprotein IIb/IIIa Inhibition with Coronary Stenting for Acute Myocardial Infarction

Gilles Montalescot, Paul Barragan, Olivier Wittenberg et al. · New England Journal of Medicine · 2001 · 1.2K citations · Full text

Medicine, Cardiology, Pharmacology +14

Ticagrelor in patients with diabetes and stable coronary artery disease with a history of previous percutaneous coronary intervention (THEMIS-PCI): a phase 3, placebo-controlled, randomised trial

Deepak L. Bhatt, Philippe Gabríel Steg, Shamir R Mehta et al. · The Lancet · 2019 · 210 citations · Full text

Medicine, Cardiology, Pharmacotherapy +15

High On-Treatment Platelet Reactivity After Prasugrel Loading Dose and Cardiovascular Events After Percutaneous Coronary Intervention in Acute Coronary Syndromes

Laurent Bonello, Michel Pansiéri, Julien Mancini et al. · Journal of the American College of Cardiology · 2011 · 208 citations

Medicine, Cardiology, Pharmacology +17

Ticagrelor versus clopidogrel in elective percutaneous coronary intervention (ALPHEUS): a randomised, open-label, phase 3b trial

Johanne Silvain, Benoît Lattuca, Farzin Beygui et al. · The Lancet · 2020 · 130 citations

Medicine, Cardiology, Pharmacology +14

Relationship between post‐treatment platelet reactivity and ischemic and bleeding events at 1‐year follow‐up in patients receiving prasugrel

Laurent Bonello, Julien Mancini, Michel Pansiéri et al. · Journal of Thrombosis and Haemostasis · 2012 · 126 citations · Full text

Medicine, Cardiology, Pharmacology +17